Interestingly, as it is sometimes difficult to differentiate GML from chronic gastritis or reactive lymphoid hyperplasia, a new immunohistochemical biomarker IRTA1 (Immunoglobulin superfamily Receptor Translocation-Associated 1) can be used, as this receptor can be expressed in nearly 43% of GML [47]. Here, FCRL4 is linked to pseudolymphoma.